- Browse by Subject
Browsing by Subject "stem cell research"
Now showing 1 - 10 of 27
Results Per Page
Sort Options
Item Emerging regulatory issues for human stem cell medicine(ESRC Genomics Network, 2005-02) Liddell, Kathleen; Wallace, SusanDiscusses the issues involved in regulating the products of stem cell research in the United Kingdom.Item Ethical issues in human stem cell research. Volume I. Report and recommendations of the National Bioethics Advisory Commission.(1999-09) United States. National Bioethics Advisory CommissionClinton administration report on the bioethical issues of stem cell research.Item Ethical issues in human stem cell research. Volume II. Commissioned papers.(2000-01) United States. National Bioethics Advisory CommissionClinton administration perspectives of the bioethical issues of stem cell research. Contains ten papers.Item Ethical issues in human stem cell research. Volume III. Religious perspectives.(2000-06) United States. National Bioethics Advisory CommissionViewpoints of religious scholars and leaders on the ethical issues of stem cell research. Contains ten articles, referred to as "testimonies".Item Human cloning and embryonic stem cell research after Seoul. [Additional information (2)](U.S. Government Printing Office, 2006-03-07) United States. Congress. House. Committee on Government Reform. Subcommittee on Criminal Justice, Drug Policy, and Human Resources.Full text of the congressional hearing discussing the ethical issues raised by stem cell research recently conducted in Seoul, South Korea. Issues include human cloning for the purpose of producing human stem cells. [Opening statements] contains the opening statements of the congressional committee. [Battey] contains the testimony and prepared statement of James F. Battey, National Institutes of Health (NIH) Stem Cell Task Force chair. [Schwetz] contains the testimony and prepared statement of Bernard A. Schwetz, director of the Office for Human Research Protections, U.S. Department of Health and Human Services. [Pascal] contains the testimony and prepared statement of Chris B. Pascal, director of the Office of Research Integrity, U.S. Department of Health and Human Services. [Panel 1 questioning] contains the questioning of the first panel, consisting of Battey, Schwetz, and Pascal. [Chole] contains the testimony and prepared statement of stem cell researcher Dr. Richard A. Chole. [Norsigian] contains the testimony and prepared statement of Judy Norsigian, co-author of "Our Bodies Ourselves" and women's health advocate. [Brown] contains the testimony and prepared statement of patient advocate Joe Brown. [Beeson] contains the testimony and prepared statement of Diane Beeson, professor at California State University, East Bay. [Doerflinger] contains the testimony and prepared statement of pro-life advocate Richard M. Doerflinger. [Mathews] contains the testimony and prepared statement of Debra Mathews, scientist and bioethics scholar. [Panel 2 questioning] contains the questioning of the second panel, consisting of Chole, Norsigian, Brown, Beeson, Doerflinger, and Mathews. [Additional information (1)] contains additional information submitted. [Follow-up questions] contains follow-up questions for both panels. [Uniform requirements for manuscripts] contains the document "Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication." [Hinxton Group] contains a statement from The Hinxton Group, "An International Consortium on Stem Cells, Ethics, and Law." [Values in conflict] contains the document "Values in Conflict: Public Attitudes on Embryonic Stem Cell Research." [Additional information (2)] contains additional information submitted.Item Human cloning and embryonic stem cell research after Seoul. [Battey](U.S. Government Printing Office, 2006-03-07) United States. Congress. House. Committee on Government Reform. Subcommittee on Criminal Justice, Drug Policy, and Human Resources.; Battey, James F.Full text of the congressional hearing discussing the ethical issues raised by stem cell research recently conducted in Seoul, South Korea. Issues include human cloning for the purpose of producing human stem cells. [Opening statements] contains the opening statements of the congressional committee. [Battey] contains the testimony and prepared statement of James F. Battey, National Institutes of Health (NIH) Stem Cell Task Force chair. [Schwetz] contains the testimony and prepared statement of Bernard A. Schwetz, director of the Office for Human Research Protections, U.S. Department of Health and Human Services. [Pascal] contains the testimony and prepared statement of Chris B. Pascal, director of the Office of Research Integrity, U.S. Department of Health and Human Services. [Panel 1 questioning] contains the questioning of the first panel, consisting of Battey, Schwetz, and Pascal. [Chole] contains the testimony and prepared statement of stem cell researcher Dr. Richard A. Chole. [Norsigian] contains the testimony and prepared statement of Judy Norsigian, co-author of "Our Bodies Ourselves" and women's health advocate. [Brown] contains the testimony and prepared statement of patient advocate Joe Brown. [Beeson] contains the testimony and prepared statement of Diane Beeson, professor at California State University, East Bay. [Doerflinger] contains the testimony and prepared statement of pro-life advocate Richard M. Doerflinger. [Mathews] contains the testimony and prepared statement of Debra Mathews, scientist and bioethics scholar. [Panel 2 questioning] contains the questioning of the second panel, consisting of Chole, Norsigian, Brown, Beeson, Doerflinger, and Mathews. [Additional information (1)] contains additional information submitted. [Follow-up questions] contains follow-up questions for both panels. [Uniform requirements for manuscripts] contains the document "Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication." [Hinxton Group] contains a statement from The Hinxton Group, "An International Consortium on Stem Cells, Ethics, and Law." [Values in conflict] contains the document "Values in Conflict: Public Attitudes on Embryonic Stem Cell Research." [Additional information (2)] contains additional information submitted.Item Human cloning and embryonic stem cell research after Seoul. [Beeson](U.S. Government Printing Office, 2006-03-07) United States. Congress. House. Committee on Government Reform. Subcommittee on Criminal Justice, Drug Policy, and Human Resources.; Beeson, DianeFull text of the congressional hearing discussing the ethical issues raised by stem cell research recently conducted in Seoul, South Korea. Issues include human cloning for the purpose of producing human stem cells. [Opening statements] contains the opening statements of the congressional committee. [Battey] contains the testimony and prepared statement of James F. Battey, National Institutes of Health (NIH) Stem Cell Task Force chair. [Schwetz] contains the testimony and prepared statement of Bernard A. Schwetz, director of the Office for Human Research Protections, U.S. Department of Health and Human Services. [Pascal] contains the testimony and prepared statement of Chris B. Pascal, director of the Office of Research Integrity, U.S. Department of Health and Human Services. [Panel 1 questioning] contains the questioning of the first panel, consisting of Battey, Schwetz, and Pascal. [Chole] contains the testimony and prepared statement of stem cell researcher Dr. Richard A. Chole. [Norsigian] contains the testimony and prepared statement of Judy Norsigian, co-author of "Our Bodies Ourselves" and women's health advocate. [Brown] contains the testimony and prepared statement of patient advocate Joe Brown. [Beeson] contains the testimony and prepared statement of Diane Beeson, professor at California State University, East Bay. [Doerflinger] contains the testimony and prepared statement of pro-life advocate Richard M. Doerflinger. [Mathews] contains the testimony and prepared statement of Debra Mathews, scientist and bioethics scholar. [Panel 2 questioning] contains the questioning of the second panel, consisting of Chole, Norsigian, Brown, Beeson, Doerflinger, and Mathews. [Additional information (1)] contains additional information submitted. [Follow-up questions] contains follow-up questions for both panels. [Uniform requirements for manuscripts] contains the document "Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication." [Hinxton Group] contains a statement from The Hinxton Group, "An International Consortium on Stem Cells, Ethics, and Law." [Values in conflict] contains the document "Values in Conflict: Public Attitudes on Embryonic Stem Cell Research." [Additional information (2)] contains additional information submitted.Item Human cloning and embryonic stem cell research after Seoul. [Brown](U.S. Government Printing Office, 2006-03-07) United States. Congress. House. Committee on Government Reform. Subcommittee on Criminal Justice, Drug Policy, and Human Resources.; Brown, JoeFull text of the congressional hearing discussing the ethical issues raised by stem cell research recently conducted in Seoul, South Korea. Issues include human cloning for the purpose of producing human stem cells. [Opening statements] contains the opening statements of the congressional committee. [Battey] contains the testimony and prepared statement of James F. Battey, National Institutes of Health (NIH) Stem Cell Task Force chair. [Schwetz] contains the testimony and prepared statement of Bernard A. Schwetz, director of the Office for Human Research Protections, U.S. Department of Health and Human Services. [Pascal] contains the testimony and prepared statement of Chris B. Pascal, director of the Office of Research Integrity, U.S. Department of Health and Human Services. [Panel 1 questioning] contains the questioning of the first panel, consisting of Battey, Schwetz, and Pascal. [Chole] contains the testimony and prepared statement of stem cell researcher Dr. Richard A. Chole. [Norsigian] contains the testimony and prepared statement of Judy Norsigian, co-author of "Our Bodies Ourselves" and women's health advocate. [Brown] contains the testimony and prepared statement of patient advocate Joe Brown. [Beeson] contains the testimony and prepared statement of Diane Beeson, professor at California State University, East Bay. [Doerflinger] contains the testimony and prepared statement of pro-life advocate Richard M. Doerflinger. [Mathews] contains the testimony and prepared statement of Debra Mathews, scientist and bioethics scholar. [Panel 2 questioning] contains the questioning of the second panel, consisting of Chole, Norsigian, Brown, Beeson, Doerflinger, and Mathews. [Additional information (1)] contains additional information submitted. [Follow-up questions] contains follow-up questions for both panels. [Uniform requirements for manuscripts] contains the document "Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication." [Hinxton Group] contains a statement from The Hinxton Group, "An International Consortium on Stem Cells, Ethics, and Law." [Values in conflict] contains the document "Values in Conflict: Public Attitudes on Embryonic Stem Cell Research." [Additional information (2)] contains additional information submitted.Item Human cloning and embryonic stem cell research after Seoul. [Chole](U.S. Government Printing Office, 2006-03-07) United States. Congress. House. Committee on Government Reform. Subcommittee on Criminal Justice, Drug Policy, and Human Resources.; Chole, Richard A.Full text of the congressional hearing discussing the ethical issues raised by stem cell research recently conducted in Seoul, South Korea. Issues include human cloning for the purpose of producing human stem cells. [Opening statements] contains the opening statements of the congressional committee. [Battey] contains the testimony and prepared statement of James F. Battey, National Institutes of Health (NIH) Stem Cell Task Force chair. [Schwetz] contains the testimony and prepared statement of Bernard A. Schwetz, director of the Office for Human Research Protections, U.S. Department of Health and Human Services. [Pascal] contains the testimony and prepared statement of Chris B. Pascal, director of the Office of Research Integrity, U.S. Department of Health and Human Services. [Panel 1 questioning] contains the questioning of the first panel, consisting of Battey, Schwetz, and Pascal. [Chole] contains the testimony and prepared statement of stem cell researcher Dr. Richard A. Chole. [Norsigian] contains the testimony and prepared statement of Judy Norsigian, co-author of "Our Bodies Ourselves" and women's health advocate. [Brown] contains the testimony and prepared statement of patient advocate Joe Brown. [Beeson] contains the testimony and prepared statement of Diane Beeson, professor at California State University, East Bay. [Doerflinger] contains the testimony and prepared statement of pro-life advocate Richard M. Doerflinger. [Mathews] contains the testimony and prepared statement of Debra Mathews, scientist and bioethics scholar. [Panel 2 questioning] contains the questioning of the second panel, consisting of Chole, Norsigian, Brown, Beeson, Doerflinger, and Mathews. [Additional information (1)] contains additional information submitted. [Follow-up questions] contains follow-up questions for both panels. [Uniform requirements for manuscripts] contains the document "Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication." [Hinxton Group] contains a statement from The Hinxton Group, "An International Consortium on Stem Cells, Ethics, and Law." [Values in conflict] contains the document "Values in Conflict: Public Attitudes on Embryonic Stem Cell Research." [Additional information (2)] contains additional information submitted.Item Human cloning and embryonic stem cell research after Seoul. [Doerflinger](U.S. Government Printing Office, 2006-03-07) United States. Congress. House. Committee on Government Reform. Subcommittee on Criminal Justice, Drug Policy, and Human Resources.; Doerflinger, Richard M.Full text of the congressional hearing discussing the ethical issues raised by stem cell research recently conducted in Seoul, South Korea. Issues include human cloning for the purpose of producing human stem cells. [Opening statements] contains the opening statements of the congressional committee. [Battey] contains the testimony and prepared statement of James F. Battey, National Institutes of Health (NIH) Stem Cell Task Force chair. [Schwetz] contains the testimony and prepared statement of Bernard A. Schwetz, director of the Office for Human Research Protections, U.S. Department of Health and Human Services. [Pascal] contains the testimony and prepared statement of Chris B. Pascal, director of the Office of Research Integrity, U.S. Department of Health and Human Services. [Panel 1 questioning] contains the questioning of the first panel, consisting of Battey, Schwetz, and Pascal. [Chole] contains the testimony and prepared statement of stem cell researcher Dr. Richard A. Chole. [Norsigian] contains the testimony and prepared statement of Judy Norsigian, co-author of "Our Bodies Ourselves" and women's health advocate. [Brown] contains the testimony and prepared statement of patient advocate Joe Brown. [Beeson] contains the testimony and prepared statement of Diane Beeson, professor at California State University, East Bay. [Doerflinger] contains the testimony and prepared statement of pro-life advocate Richard M. Doerflinger. [Mathews] contains the testimony and prepared statement of Debra Mathews, scientist and bioethics scholar. [Panel 2 questioning] contains the questioning of the second panel, consisting of Chole, Norsigian, Brown, Beeson, Doerflinger, and Mathews. [Additional information (1)] contains additional information submitted. [Follow-up questions] contains follow-up questions for both panels. [Uniform requirements for manuscripts] contains the document "Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication." [Hinxton Group] contains a statement from The Hinxton Group, "An International Consortium on Stem Cells, Ethics, and Law." [Values in conflict] contains the document "Values in Conflict: Public Attitudes on Embryonic Stem Cell Research." [Additional information (2)] contains additional information submitted.
- «
- 1 (current)
- 2
- 3
- »